Soleno Therapeutics (SLNO) Other Working Capital Changes (2013 - 2026)
Soleno Therapeutics (SLNO) reported Other Working Capital Changes of -$133000.0 for Q1 2026, down 103.89% year-over-year from $3.4 million in Q1 2025, and down 103.85% quarter-over-quarter from $3.5 million in Q4 2025.
Soleno Therapeutics (SLNO) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 14 years of Other Working Capital Changes data on file, last reported at -$133000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$133000.0, down 103.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (down 71.47% YoY), and the FY2025 annual result was $4.7 million, up 531.73% from the prior year.
- Other Working Capital Changes declined to -$133000.0 in Q1 2026 per SLNO's latest filing, from $3.5 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.5 million in Q4 2025 and troughed at -$3.1 million in Q2 2025.
- A 5-year average of $279058.8 and a median of -$6000.0 in 2022 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes plunged 5466.67% in 2023, then jumped 341700.0% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $35000.0 in 2022, then sank by 291.43% to -$67000.0 in 2023, then jumped by 1635.82% to $1.0 million in 2024, then surged by 235.37% to $3.5 million in 2025, then plunged by 103.85% to -$133000.0 in 2026.
- Business Quant data shows SLNO's Other Working Capital Changes at -$133000.0 in Q1 2026, $3.5 million in Q4 2025, and $948000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133,000.00 |
| Mar 31, 2026 | -133,000.00 |
| Dec 31, 2025 | 3.45 Mn |
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 948,000.00 |
| Sep 30, 2025 | 948,000.00 |
| Jun 30, 2025 | -3.08 Mn |
| Jun 30, 2025 | -3.08 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Mar 31, 2025 | 3.42 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 101,000.00 |
| Sep 30, 2024 | 101,000.00 |
| Jun 30, 2024 | -379,000.00 |
| Jun 30, 2024 | -379,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -67,000.00 |
| Dec 31, 2023 | -67,000.00 |